Jeane Rebecca Roy

Mrs. Jeane Rebecca Roy

Bharath University, Chennai, India
+1
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Green Processing and Synthesis
Verified
Journal Article
Open access
PDF file
JPJinjin Pei
Jinjin Pei
YYYuqiang Yan
Yuqiang Yan
Chella Perumal PalanisamyChella Perumal Palanisamy
Chella Perumal Palanisamy
SJSelvaraj Jayaraman
Selvaraj Jayaraman
PMPrabhu ManickamNatarajan
Prabhu ManickamNatarajan
MMMonica MIRONESCU
Monica MIRONESCU
Materials-based drug delivery approaches have garnered substantial attention in recent years due to their potential to revolutionize pharmaceutical interventions. This abstract provides a concise overview of recent advancements and future prospects in this rapidly evolving field. Materials such as nanoparticles, liposomes, polymers, and hydrogels have emerged as versatile carriers for drug delivery. These materials facilitate precise control over drug release kinetics, enabling targeted and sustained therapeutic effects. Smart materials with responsiveness to external stimuli or physiological conditions have further enhanced drug delivery precision. Personalized medicine approaches are gaining traction, tailoring drug delivery systems to individual patient profiles and needs. The horizon for materials-based drug delivery is bright. Ongoing research is focused on refining material design, streamlining production processes, and ensuring safety profiles. Collaborative efforts among researchers, clinicians, and industry stakeholders are crucial for translating these advancements into clinical practice. Additionally, the convergence of drug delivery with diagnostics and imaging holds immense potential for personalized and efficient healthcare solutions. As materials-based drug delivery continues to evolve, it stands poised to reshape the landscape of pharmaceuticals, offering the promise of more effective and patient-centered therapies for a wide range of medical conditions.

29 May 2024 in Ageing Research Reviews
Verified
Journal Article
Closed access
JPJinjin Pei
Jinjin Pei
Chella Perumal PalanisamyChella Perumal Palanisamy
Chella Perumal Palanisamy
SJSelvaraj Jayaraman
Selvaraj Jayaraman
PMPrabhu ManickamNatarajan
Prabhu ManickamNatarajan
Vidhya Rekha UmapathyVidhya Rekha Umapathy
Vidhya Rekha Umapathy
MMMonica MIRONESCU
Monica MIRONESCU

21 October 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
JRJeane Rebecca Roy
Jeane Rebecca Roy
CJCoimbatore Sadagopan Janaki
Coimbatore Sadagopan Janaki
SJSelvaraj Jayaraman
Selvaraj Jayaraman
VPvijayalakshmi periysamy
vijayalakshmi periysamy
TBThotakura Balaji
Thotakura Balaji
VVVishnu Priya Veeraraghavan
Vishnu Priya Veeraraghavan
In the management of type 2 diabetes, oral antidiabetic drugs have several side effects, which in turn have led the pharmaceutical industry to search for good therapeutic, non-toxic and reliable drugs. Carica papaya (C. papaya) is one of several plants in nature that have been found to possess anti-diabetic properties. Despite studies being focused on the antidiabetic activity of C. papaya, the molecular mechanism against high fat diet induced insulin resistance is yet to be identified. The role of C. papaya was evaluated on insulin signaling molecules, such as the insulin receptor (IR) and glucose transporter-4 (GLUT4) in high fat, diet-streptozotocin induced type 2 diabetic rats, and analyzed the bioactive compounds of C. papaya against IR and GLUT4 via molecular docking and dynamics. The ethanolic extract of C. papaya leaves (600 mg/kg of body weight) was given daily to male wistar rats for 45 days and we observed the various biochemical parameters, gene expression analysis and histopathology of skeletal muscle. Molecular docking and dynamics were undertaken to understand the bioactive compounds with the greatest hit rate. C. papaya treatment was able to control blood glucose levels, the lipid profile and serum insulin, but it facilitated tissue antioxidant enzymes and IR and GLUT4 levels. The in-silico study showed that kaempferol, quercitin and transferulic acid were the top three ligands with the greatest hit rate against the protein targets. Our preliminary findings, for the first time, showed that C. papaya reinstates the glycemic effect in the diabetic skeletal muscle by accelerating the expression of IR and GLUT4.

1 March 2023 in Toxics
Verified
Journal Article
Open access
PDF file
JRJeane Rebecca Roy
Jeane Rebecca Roy
CJCoimbatore Sadagopan Janaki
Coimbatore Sadagopan Janaki
SJSelvaraj Jayaraman
Selvaraj Jayaraman
VVVishnu Priya Veeraraghavan
Vishnu Priya Veeraraghavan
VPVijayalakshmi Periyasamy
Vijayalakshmi Periyasamy
PSPanneerselvam Swetha
Panneerselvam Swetha
Regardless of socioeconomic or demographic background, the prevalence of type 2 diabetes mellitus, which affects more than half a billion people worldwide, has been steadily increasing over time. The health, emotional, sociological, and economic well-being of people would suffer if this number is not successfully handled. The liver is one of the key organs accountable for sustaining metabolic balance. Elevated levels of reactive oxygen species inhibit the recruitment and activation of IRS-1, IRS-2, and PI3K-Akt downstream signaling cascade. These signaling mechanisms reduce hepatic glucose absorption and glycogenesis while increasing hepatic glucose output and glycogenolysis. In our work, an analysis of the molecular mechanism of Carica papaya in mitigating hepatic insulin resistance in vivo and in silico was carried out. The gluconeogenic enzymes, glycolytic enzymes, hepatic glycogen tissue concentration, oxidative stress markers, enzymatic antioxidants, protein expression of IRS-2, PI3K, SREBP-1C, and GLUT-2 were evaluated in the liver tissues of high-fat-diet streptozotocin-induced type 2 diabetic rats using q-RT-PCR as well as immunohistochemistry and histopathology. Upon treatment, C. papaya restored the protein and gene expression in the liver. In the docking analysis, quercetin, kaempferol, caffeic acid, and p-coumaric acid present in the extract were found to have high binding affinities against IRS-2, PI3K, SREBP-1c, and GLUT-2, which may have contributed much to the antidiabetic property of C. papaya. Thus, C. papaya was capable of restoring the altered levels in the hepatic tissues of T2DM rats, reversing hepatic insulin resistance.

Verified
Journal Article
Open access
PDF file
JRJeane Rebecca Roy
Jeane Rebecca Roy
CJCoimbatore Sadagopan Janaki
Coimbatore Sadagopan Janaki
SJSelvaraj Jayaraman
Selvaraj Jayaraman
VPVijayalakshmi Periyasamy
Vijayalakshmi Periyasamy
TBThotakura Balaji
Thotakura Balaji
MPMonisha Prasad
Monisha Prasad
The prevalence of obesity in contemporary society has brought attention to how serious it is all around the world. Obesity, a proinflammatory condition defined by hypertrophied adipocytes and immune cells that reside in adipose tissue, is characterized by elevated circulating levels of proinflammatory cytokines. The pro-inflammatory mediators trigger a number of inflammatory pathways and affect the phosphorylation of a number of insulin-signaling pathways in peripheral tissues. In this work, we pointed the outcome of the leaves of Carica papaya (C. papaya) on the inflammatory molecules by in vivo and in silico analysis in order to prove its mechanisms of action. Adipocytokines, antioxidant enzymes, gene and protein expression of pro-inflammatory signaling molecules (mTOR, TNF-α, IL-1β, IL-6 and IKKβ) by q-RT-PCR and immunohistochemistry, as well as histopathological analysis, in adipose tissues were carried out. C. papaya reinstated the levels of adipocytokines, antioxidant enzymes and mRNA levels of mTOR, TNF-α, IL-1β, IL-6 and IKKβ in the adipose tissues of type 2 diabetic rats. Molecular docking and dynamics simulation studies revealed that caffeic acid, transferulic acid and quercetin had the top hit rates against IKKβ, TNF-α, IL-6, IL-1β, and mTOR. This study concludes that C. papaya put back the altered effects in fatty tissue of type 2 diabetic rats by restoring the adipocytokines and the gene expression.

8 October 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
JRJeane Rebecca Roy
Jeane Rebecca Roy
CJCoimbatore Sadagopan Janaki
Coimbatore Sadagopan Janaki
SJSelvaraj Jayaraman
Selvaraj Jayaraman
VPVijayalakshmi Periyasamy
Vijayalakshmi Periyasamy
TBThotakura Balaji
Thotakura Balaji
VVVishnu Priya Veeraraghavan
Vishnu Priya Veeraraghavan
Despite rigorous endeavors, existing attempts to handle type 2 diabetes (T2DM) are still a long way off, as a substantial number of patients do not meet therapeutic targets. Insulin resistance in skeletal muscle is discerned as a forerunner in the pathogenesis of T2DM and can be detected years before its progress. Studies have revealed the antidiabetic properties of Carica papaya (C. papaya), but its molecular mechanism on insulin receptor substrate-1 (IRS-1)/Akt signaling mechanisms is not yet known. The present study aimed to evaluate the role of C. papaya on IRS1 and Akt in high-fat-diet–streptozotocin-induced type 2 diabetic rats and also to analyze the bioactive compounds of C. papaya against IRS-1 and Akt via in silico analysis. Ethanolic extract of the leaves of C. papaya (600 mg/kg of body weight) was given daily for 45 days postinduction of T2DM up to the end of the study. Gluconeogenic enzymes, glycolytic enzymes, gene expression, and immunohistochemical analysis of IRS-1 and Akt in skeletal muscle were evaluated. C. papaya treatment regulated the levels of gluconeogenic and glycolytic enzymes and the levels of IRS-1 and Akt in skeletal muscle of type 2 diabetic animals. In silico studies showed that trans-ferulic acid had the greatest hit rate against the protein targets IRS-1 and Akt. C. papaya restored the normoglycemic effect in diabetic skeletal muscle by accelerating the expression of IRS-1 and Akt.
1